Created in 2017 by Marie-Christine Levet and Litzie Maarek, Educapital is the first impact investment fund dedicated to the future of education and work. Educapital invests from late seed to series B in companies that innovate in the education and workplace sector, from early childhood to contidocnuing education. Educapital's ambition is to help European Edtech champions emerge by providing financial support and expertise. To date, Educapital has invested in 22 European Edtech companies, including Lunii, 360Learning, LiveMentor, Labster, Preply, Simundia among others.
MACSF (Mutuelle d'assurance du corps de santé français) is the leading insurer of healthcare professionals and has been serving all healthcare professionals in France for over a century. It employs 1,600 people and has a turnover of around 2 billion euros. Faithful to its vocation as a professional mutual insurance company, MACSF insures the risks of the private and professional life of more than one million members and clients.
The Fonds Patient Autonome, launched by BPIFrance, financially supports startups working on medical technology. Provided with 50 million euros, these investments aim to identify and develop the most promising French startups in the medical technology industry.
Investment funds for internet entrepreneurs. The creation of the ISAI originated in the shared desire of certain entrepreneurs coming from the IT, Communication and Web industries to structure and professionalize their direct investment into young, innovative companies.
An independent corporation supporting companies through its investment group. The funds come exclusively from the founder Patrice Mayolle, investing in many European business sectors while becoming a major partner in the development and handover of Small and Medium Sized Enterprises.
Fine Day Ventures
Fine Day Ventures is an early stage venture capital firm investing in technology, specifically financial technology, medical technology and aerospace technology, artificial intelligence and energy (alternative and traditional). Founder Claude Wasserstein has invested in a number of startups, including Blade, Hyperloop, Flare (board member), Maven, Ambulnz, BitPesa, and Tentrr.
Co-founder and CEO of Invivox, Mission: "Creation & Dissemination of content to health professionals in the event of a new health crisis" at the French Ministry of Solidarity and Health
Co-founder & Managing Director at Invivox
Invivox Board member, Venture Capital investor
Invivox board member, Medical Director at Macsf
Maud Kelly Crapeau
Invivox board member, Portfolio Management
Invivox board member, Venture Capital Investor at Bpifrance
Invivox board member, Early stage VC / Partner @ISAI
Chahra Louafi is Director of Senior Investments and Manager of Funds in Innovative Biotherapy and Rare Disease at BPIFrance (formerly CDC Enterprises), currently in charge of 10 societies. Since January 2018, she has managed the « Autonomous Patient » Funds that she herself established. Before joining CDC Enterprises in 2001 she was in charge of project management and business creation in a private business incubator specialised in the field of biotechnology.
With CDC Enterprises, attached to the New Developments team, Chahra was in charge of investments dedicated to company launch and technological transfer operations. She was President of the Surveillance Committee at Inserm Transfer Initiative. Since 2009 she has invested in young, unlisted start-ups in the health sector including DBV Technologies (listed on Euronext in 2012 and on the Nasdaq in 2014), Pixium Vision (listed on Euronext in 2014), Sensorion (listed on Altenext in 2015), Adverum (M&A then listed on the Nasdaq in 2016), Lysogene (listed on Euronext in 2017), Enyo Pharma, Eyevensys, Medday, Therachon, Gecko, Sparing Vision, Brainever and GMPO.
Chahra Louafi graduated from INA-PG (with an M.Phil in Enzymatic Engineering and Microbiology), from Université Dauphine (Postgraduate degree in Technology and Innovation Management) and from Université Paris 10-Nanterre (Postgraduate degree in Financial Management). She is a Chevalier of the National Order of Merit.